Is burning mouth syndrome associated with stress? A meta‐analysis
Journal of Oral Rehabilitation · 2023-11 · 50 (11) · 1279-1315
DOI: 10.1111/joor.13536 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Oral Rehabilitation, online erschienen am 04.07.2023. Verfasst von André Luís Porporatti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire de Neurobiologie Oro-Faciale (EA 7543), Université Paris Cité, France and GHPS Assistance Publique Hôpitaux de Paris, Paris, France. Hauptthemen laut MEDLINE: Burning Mouth Syndrome. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Some studies have shown burning mouth syndrome (BMS) as comorbid psychosocial and psychiatric disorders, and as well, pointed at stress as a major risk factor.
Objective
The aim of this meta‐analysis was to answer the following question: ‘Is there an association between BMS and stress, compared to healthy controls?’ Methods Two reviewers searched for the effect of stress in BMS and published on five main databases and three from the grey literature. Various questionnaires and biomarkers were analysed. Of the 2489 selected articles, 30 met the inclusion criteria. Studies englobed questionnaires, such as Perceived Stress Questionnaire, Lipp Stress Symptoms Inventory, Holmes‐Rahe scale, Depression, Anxiety, and Stress Scale (DASS‐21), Recent Experience Test; and various biomarkers, such as cortisol, opiorphin, IgA, α‐amylase and interleukins.
Results
In all studies with questionnaires, stress was significantly increased in the BMS group vs. control. Patients with BMS presented 25.73% higher cortisol levels, 28.17% higher IgA levels and 40.62% higher α‐amylase levels than controls. Meta‐analysis found that BMS subjects presented 3.01 nmoL/L [0.53; 5.50] higher cortisol levels, 84.35 kU/L [15.00; 153.71] higher α‐amylase levels, 29.25 mg/mL [9.86; 48.64] higher IgA levels and 258.59 pg/mL [59.24; 457.94] higher IL‐8 levels than control. No differences were found for opiorphin concentration in ng/mL [−0.96; 2.53]. For interleukins, no differences were founded for IL‐1 β, IL‐2, IL‐4, IL‐6, IL‐8, IL‐10 and TNF‐α.
Conclusion
Based on the available evidence, this meta‐analysis suggests more stress factors in questionnaire‐based studies, and higher levels of cortisol, α‐amylase, IgA and IL‐8 biomarkers in BMS subjects than controls.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratoire de Neurobiologie Oro-Faciale (EA 7543), Université Paris Cité, France and GHPS Assistance Publique Hôpitaux de Paris, Paris, France.
- NARSM (Núcleo de Revisão Sistemática e Meta-análise), Curitiba, Brazil.
- Laboratoire de Neurobiologie OroFaciale, Université Paris Cité, France and GHPS Assistance Publique Hôpitaux de Paris, Paris, France.
- Laboratoire de Neurobiologie Oro-Faciale (EA 7543), Université Paris Cité and Hôpital Bretonneau (AP-HP), Paris, France.
- Université de Bretagne Occidentale, Brest, France.
- University of Zagreb, Zagreb, Croatia.
ORCID-Profile: Adeline Braud
Zitieren
APA
Porporatti, A. L., Schroder, Â. G. D., Lebel, A., Moreau, N., Misery, L., Alajbeg, I., Braud, A., & Boucher, Y. (2023). Is burning mouth syndrome associated with stress? A meta‐analysis. Journal of Oral Rehabilitation, 50(11), 1279-1315. https://doi.org/10.1111/joor.13536
Vancouver
Porporatti AL, Schroder ÂGD, Lebel A, Moreau N, Misery L, Alajbeg I, et al. Is burning mouth syndrome associated with stress? A meta‐analysis. Journal of Oral Rehabilitation. 2023;50(11):1279-1315. doi:10.1111/joor.13536
BibTeX
@article{Porporatti2023,
author = {Porporatti, André Luís and Schroder, Ângela Graciela Deliga and Lebel, Ashley and Moreau, Nathan and Misery, Laurent and Alajbeg, Ivan and Braud, Adeline and Boucher, Yves},
title = {Is burning mouth syndrome associated with stress? A meta‐analysis},
journal = {Journal of Oral Rehabilitation},
year = {2023},
volume = {50},
number = {11},
pages = {1279--1315},
doi = {10.1111/joor.13536}
}
EUVIMED